| Stage | SAM | % of rev | PRAA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $520M | 100.00% | $372M | 100.00% | SAM ×1.40 |
| Gross profit | $269M | 51.74% | $302M | 81.09% | PRAA +29.4pp |
| Operating income | $56M | 10.83% | $153M | 41.19% | PRAA +30.4pp |
| Pre-tax income | $59M | 11.33% | $88M | 23.73% | PRAA +12.4pp |
| Net income | $43M | 8.30% | $59M | 15.84% | PRAA +7.5pp |
| Stage | SAM | PRAA | Gap · A − B |
|---|---|---|---|
| Revenue | $520M100.00% | $372M100.00% | SAM ×1.40 |
| Gross profit | 51.74%$269M | 81.09%$302M | PRAA +29.4pp |
| Operating income | 10.83%$56M | 41.19%$153M | PRAA +30.4pp |
| Pre-tax income | 11.33%$59M | 23.73%$88M | PRAA +12.4pp |
| Net income |
| 8.30%$43M |
| 15.84%$59M |
| PRAA +7.5pp |
No disclosed counterparties: PRAA.
None